Erweiterte Informationen für Ärzte


Kazue Shiozawa, Manabu Watanabe
Comparison of percutaneous radiofrequency ablation and CyberKnife® for initial solitary hepatocellular carcinoma: A pilot study
World J Gastroenterol
2015 December 28; 21(48): 13490-13499

Sun Hyun Bae,1 Mi-Sook Kim
Low Hepatic Toxicity in Primary and Metastatic Liver Cancers after Stereotactic Ablative Radiotherapy Using 3 Fractions
J Korean Med Sci. 2015 Aug; 30(8): 1055–1061.

Journal of Oncology, Volume 2015 (2015), Article ID 547143
Stereotactic Ablative Radiotherapy for the Treatment of Clinically Localized Renal Cell Carcinoma

Cancer. 2015 Apr 1;121(7):1128-37. doi: 10.1002/cncr.29161. Epub 2014 Dec 23.
Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma.

Ann Surg Onco. 2015 July ; 22(7): 2352–2358. doi:10.1245/s10434-014-4274-5.
The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution Experience

Front. Oncol., 17 March 2015
Stereotactic ablative radiosurgery for locally advanced or recurrent skull base malignancies with prior external beam radiation therapy

Radiotherapy & Oncology January 2015 Volume 114, Issue 1, Pages 109–116
SBRT in pancreatic cancer: What is the therapeutic window?

International Journal of Radiation Oncology March 1, 2015 Volume 91, Issue 3, Pages 480–488
A Prospective Phase 2 Trial of Reirradiation With Stereotactic Body Radiation Therapy Plus Cetuximab in Patients With Previously Irradiated Recurrent Squamous Cell Carcinoma of the Head and Neck

Front. Oncol., 22 January 2015 | doi: 10.3389/fonc.2014.00369
Multi-institutional registry for prostate cancer radiosurgery: a prospective observational clinical trial